Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,124.00
-19.00 (-1.66%)
Mar 11, 2026, 1:31 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 130.47 million as of March 11, 2026. Its market cap has decreased by -18.94% in one year.
Market Cap
130.47M
Enterprise Value
260.04M
Revenue
300.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,124.00
Market Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 130.47M, an increase of 20.90%. That is a compound annual growth rate of 0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 130.47M | 4.48% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.71B |
| Danel (Adir Yeoshua) | 2.83B |
| BrainsWay | 1.58B |
| Kamada | 1.56B |
| Geffen Residence & Renewal | 270.18M |
| Epitomee Medical | 242.65M |
| Golden House | 166.80M |
| Matricelf | 146.87M |